The growth of Viagra and its impact on the medicinal landscape presents a intricate question for shareholders. While the initial sales figures were impressive, the exclusivity has ended, leading to a flood of generic https://lilliewlr060762.blogoxo.com/41773915/the-blue-pill-and-the-pharmaceutical-industry-a-risky-opportunity